Clinical Trial Update: QLS12010 Capsules in Adults With Moderate to Severe Hidradenitis Suppurativa [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating QLS12010 capsules in adults with moderate-to-severe hidradenitis suppurativa; the study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• QLS12010

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Adults With Moderate-to-severe Hidradenitis Suppurativa | Phase 2 | Status: NOT_YET_RECRUITING